SUPN: Supernus Pharmaceuticals Inc
SUPN exchange rate has changed by 1.99% for today. During the day, the instrument was traded at a low of 49.4600 and at a high of 51.4000.
Follow Supernus Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SUPN News
- BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
- New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
- Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)
- Supernus Pharmaceuticals amends merger agreement to adjust milestone payments
- Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock
- Stifel raises Supernus Pharmaceuticals stock price target to $55 from $50
- Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript
- Supernus at Jefferies Conference: Strategic Growth and Challenges
- Stifel raises Supernus Pharmaceuticals stock price target to $50 on strong Q3
- Micron and McDonald’s among market cap stock movers on Wednesday
- Supernus Pharmaceuticals, Inc. (SUPN) Q3 2025 Earnings Call Transcript
- Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say
- Supernus earnings missed by $0.94, revenue topped estimates
- Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue Estimates
- BIIB Beats on Q3 Earnings & Sales, Stock Down on Lowered '25 EPS View
- Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
- BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates
- Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy
- Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline
- BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock?
- Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run?
- Will Biogen Beat on Q3 Earnings? Leqembi, Skyclarys Could Hold the Key
- Piper Sandler sees biotech sector entering new upcycle, names 17 stocks to own
- Shareholder Value Creation In An Expanded Addressable Market
Frequently Asked Questions
What is SUPN stock price today?
Supernus Pharmaceuticals Inc stock is priced at 50.8400 today. It trades within 49.4600 - 51.4000, yesterday's close was 49.8500, and trading volume reached 1473. The live price chart of SUPN shows these updates.
Does Supernus Pharmaceuticals Inc stock pay dividends?
Supernus Pharmaceuticals Inc is currently valued at 50.8400. Dividend policy depends on the company, while investors also watch -5.85% and USD. View the chart live to track SUPN movements.
How to buy SUPN stock?
You can buy Supernus Pharmaceuticals Inc shares at the current price of 50.8400. Orders are usually placed near 50.8400 or 50.8430, while 1473 and 1.99% show market activity. Follow SUPN updates on the live chart today.
How to invest into SUPN stock?
Investing in Supernus Pharmaceuticals Inc involves considering the yearly range 43.1100 - 57.6500 and current price 50.8400. Many compare 5.56% and -5.85% before placing orders at 50.8400 or 50.8430. Explore the SUPN price chart live with daily changes.
What are Supernus Pharmaceuticals Inc stock highest prices?
The highest price of Supernus Pharmaceuticals Inc in the past year was 57.6500. Within 43.1100 - 57.6500, the stock fluctuated notably, and comparing with 49.8500 helps spot resistance levels. Track Supernus Pharmaceuticals Inc performance using the live chart.
What are Supernus Pharmaceuticals Inc stock lowest prices?
The lowest price of Supernus Pharmaceuticals Inc (SUPN) over the year was 43.1100. Comparing it with the current 50.8400 and 43.1100 - 57.6500 shows potential long-term entry points. Watch SUPN moves on the chart live for more details.
When did SUPN stock split?
Supernus Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 49.8500, and -5.85% after corporate actions.
- Previous Close
- 49.8500
- Open
- 49.8500
- Bid
- 50.8400
- Ask
- 50.8430
- Low
- 49.4600
- High
- 51.4000
- Volume
- 1.473 K
- Daily Change
- 1.99%
- Month Change
- 5.56%
- 6 Months Change
- -5.85%
- Year Change
- -5.85%
- Act
- Fcst
- Prev